FGAM
BNTX icon

Financial Gravity Asset Management’s BioNTech BNTX Stock Holding History

Financial Gravity Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2
Closed -$178 – 1461
2024
Q1 		$178 Buy
+2
New +$192 ﹤0.01% 943

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Financial Gravity Asset Management's BNTX Position: Q2 2024 in Review

Financial Gravity Asset Management sold out of BioNTech (BNTX) in Q2 2024, closing a stake of 2 shares — an estimated $178 sold.

Financial Gravity Asset Management first reported a position in BNTX in Q1 2024 and held it in 1 quarter. The position peaked at $178 in Q1 2024. 286 funds tracked by Wall St. Rank hold BNTX as of Q2 2024.

  • Financial Gravity Asset Management reported no remaining BioNTech position as of Q2 2024 after selling out during the quarter.
  • Financial Gravity Asset Management sold 2 BioNTech shares in Q2 2024, an estimated $178.
  • Financial Gravity Asset Management first reported a position in BioNTech in Q1 2024 and held it in 1 quarter.
  • Financial Gravity Asset Management's BioNTech position peaked at $178 in Q1 2024.
  • 286 funds tracked by Wall St. Rank held BioNTech as of Q2 2024.

Based on Financial Gravity Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.